Industrial-grade precision, pharmacopoeial monograph verification, and supply-chain resilience for global nutraceutical, active pharmaceutical intermediate, and high-performance functional formulation manufacturers.
Verified against USP, EP, CP, and FCC pharmacopoeial specifications with complete batch COA documentation and continuous supply readiness.
Addressing the mission-critical auditing, validation, and functional parameters required by enterprise formulation chemists and tier-1 corporate procurement officers.
Global pharmaceutical and nutraceutical brands mandate unambiguous chromatographic profiling. Whether validating Biotin (Vitamin B7) via titration or confirming Cycloastragenol assay above 98% by reverse-phase HPLC, our production criteria guarantee strictly aligned retention times and absolute reproducibility per lot.
Direct compression, sachet dissolution, and modern RTD (Ready-To-Drink) formulations require strict physical characterization. We engineer tapped density, flowability (Carr’s Index), particle sizing (80 to 200 mesh), and cold-water dispersibility for seamless automated plant throughput.
Suppliers must eliminate supply-chain vulnerability through heavy metal ICP-MS screening (Pb <0.5ppm, As <0.5ppm, Cd <0.1ppm, Hg <0.1ppm), USP <467> residual solvent limits, and zero ethylene oxide (ETO) residues, fully satisfying EU Novel Food and California Prop 65 mandates.
Combining proprietary multi-stage extraction architectures, continuous crystallization corridors, and digital batch auditing in the core biological corridor of Xi'an.
Situated in the Hi-Tech Zone of Xi'an and drawing raw materials directly from the Qinling ecological corridor, our 8,600m² manufacturing facility operates under automated Distributed Control Systems (DCS). Every process variable—countercurrent extraction velocity, negative pressure vacuum concentration temperatures, and centrifugal spray-drying cyclonic cycles—is tracked in real time to prevent thermal active degradation.
By pairing modern engineering with high-capacity continuous fermentation tanks, we produce bio-active carbohydrates like D-Allulose, essential bio-molecules like ATP, and bioactive lipids like D-Alpha Tocopherol with total batch consistency and reduced unit operational overhead.
| Operational Parameter | Legacy Industry Benchmarks | ShineHerb Factory 4.0 Standard |
|---|---|---|
| Process Control | Manual intervention & chart logs | Full Automated DCS & SCADA tracking |
| Assay Batch Variance | ± 3.5% across production lots | < 0.8% variance via HPLC closed loops |
| Traceability Speed | 48–72 hours paper search | Instant digital trace (Farm to Sealed Drum) |
| Continuous Output | 50–80 MT / Month intermittent | 350+ MT / Month uninterrupted capacity |
Targeted bio-molecular solutions developed specifically for tier-one sports nutrition brands, medical-grade cosmecuticals, and advanced functional foods.
Integrating high-purity Cycloastragenol 98% with cellular precursors like Pyrroloquinoline Quinone (PQQ Disodium Salt) and Adenosine Triphosphate (ATP) to address telomere maintenance, mitochondrial biogenesis, and ATP-driven cellular restoration.
Replacing high-calorie carbohydrate fillers with biologically inactive natural sugars such as crystallized D-Allulose and non-digestible Alpha Cyclodextrins, paired with plant-origin Corn Protein Peptides for post-prandial glycemic stabilization.
Providing bio-identical active peptides such as Palmitoyl Tetrapeptide-7 and oil-soluble D-Alpha Tocopherol for cosmetic formulations. Targets matrix metalloproteinase reduction, inflammatory cytokine inhibition, and deep epidermal barrier restoration.
A strategic technological blueprint engineering the next generation of bioavailability enhancement, enzymatic biotransformation, and carbon-neutral extraction.
Standard nutraceutical actives often suffer from rapid gastric hydrolysis and low intestinal absorption. Our ongoing R&D incorporates sub-micron phospholipid bilayer encapsulation for hydrophobic actives like Lycopene, Vitamin K1, and Astragalus cyclosaponins, yielding up to a 6.8x increase in systemic bioavailability.
Moving away from harsh chemical synthetic catalysts, our Xi'an laboratory utilizes immobilized multi-enzyme cascade bioreactors. This green biotransformation enables high-yield conversion of complex glycosides and pure isomer synthesis for ingredients like D-Allulose with zero environmental solvent impact.
Scaling commercial subcritical and supercritical CO2 extraction arrays. By recycling pressurized carbon dioxide within a closed loop, we isolate high-purity botanicals without thermal deterioration, eliminating atmospheric VOC emissions while preserving fragile terpene structures.
Comprehensive regulatory defense protocols designed to simplify customs border clearance and accelerate third-party vendor pre-qualification.
We supply full DSHEA-compliant technical dossiers, non-irradiated attestations, vegan/vegetarian certifications, and third-party laboratory verification (SGS / Eurofins) for seamless filing under FDA and health authority compliance audits.
All catalog products feature PAH4 toxicological clearance, pyrrolizidine alkaloid screen records, pesticide multiresidue screenings (>500 pesticides compliant with EU 396/2005), and robust documentation for novel food applications across member states.
Dedicated production halls operate under strict religious dietary controls, verified by international certification bodies. Free from pork derivatives, alcohol-free processing, and certified suitable for MENA, Southeast Asia, and Jewish consumer dietary standards.
Specialty amino acids, nutritional excipients, cosmetic peptides, and plant-derived antioxidants calibrated for advanced product formulation.
Direct answers for purchasing directors, supply chain leads, and senior formulation chemists qualifying ingredient vendors.